Therapeutic Focus

Cerimon Pharmaceuticals, Inc. is focused on bringing innovative therapeutics to patients with significant unmet medical needs in the fields of autoimmune disease, inflammation and pain. The Company currently has two drugs in development, a topical patch formulation of diclofenac sodium for the treatment of musculoskeletal pain and Simulect® (basiliximab) for the treatment of moderate-to-severe, steroid-refractory ulcerative colitis.